•Assess optimal management strategies for moderate hidradenitis suppurativa (HS) through interactive case-based discussions. •Understand the current treatment landscape for HS, focusing on the role of biologic therapy for moderate disease, and identify potential barriers for treatment initiation. •Highlight the importance of early treatment initiation in moderate HS to improve patient outcomes. •Explore the utility of ultrasound to aid in diagnosis and management of HS and navigate how ultrasound utilization might integrate into clinical practice.